https://www.diacarta.com/diacarta-demos-liquid-biopsy-use-coloscape-assay-plans-market-expanded-application2019-11-21T15:01:08-08:00https://www.diacarta.com/predict-patient-responses-immunotherapy2018-04-16T01:00:57-07:00https://www.diacarta.com/reducing-artifactual-egfr-t790m-mutations-in-dna-from-formalin-fixed-paraffin-embedded-tissue-by-use-of-thymine-dna-glycosylase2017-07-17T17:00:24-07:00https://www.diacarta.com/taqman-qpcr-assays-for-cancer-gene-mutation-detection2018-10-28T22:00:01-07:00https://www.diacarta.com/nci-contract-cancer-radiation-response-blood-test2018-10-15T01:00:47-07:00https://www.diacarta.com/confirmation-of-ngs-for-false-negative-variants2019-11-21T14:37:36-08:00https://www.diacarta.com/top-10-in-vitro-diagnostic-technology2018-07-30T22:51:35-07:00https://www.diacarta.com/arrow-diagnostics-distributor-italy2018-07-02T01:00:49-07:00https://www.diacarta.com/top-25-life-sciences-technology2018-06-04T01:00:34-07:00https://www.diacarta.com/45-million-series-b-funding2018-02-12T00:00:56-08:00https://www.diacarta.com/non-invasive-colorectal-cancer-test2017-02-19T19:01:32-08:00https://www.diacarta.com/nci-contract-cfdna-test-monitor-radiation-response2016-10-25T20:01:12-07:00https://www.diacarta.com/iso-13485-2003-certification2016-09-25T17:00:31-07:00https://www.diacarta.com/non-invasive-genetic-mutations-blood2016-04-12T17:00:04-07:00https://www.diacarta.com/clia-certification2016-03-27T17:00:33-07:00https://www.diacarta.com/alk-fusion-gene-detection2016-09-25T17:00:59-07:00https://www.diacarta.com/non-invasive-early-detection-colon-cancer-test2015-04-16T17:00:41-07:00https://www.diacarta.com/8-million-series-a-round-funding2015-01-08T21:50:03-08:00https://www.diacarta.com/ceivd-cancer-mutation-tests2014-02-25T16:00:28-08:00https://www.diacarta.com/somatic-mutation-qpcr-tests2013-10-27T17:00:53-07:00https://www.diacarta.com/xna-molecular-clamps-help-identify-false-positive-t790m-mutation2019-11-21T14:38:12-08:00https://www.diacarta.com/cancer-diagnostics-targeted-gene-panels-ngs2019-11-21T14:38:18-08:00https://www.diacarta.com/colorectal-cancer-early-screening-could-save-your-life2019-11-21T15:02:10-08:00https://www.diacarta.com/detecting-braf-v600e-mutation-in-ffpe-or-blood-samples2019-11-21T14:40:29-08:00https://www.diacarta.com/diacarta-redefining-molecular-diagnostics-through-xna2019-11-21T14:43:34-08:00https://www.diacarta.com/diacarta-democratizing-the-diagnosis-process2019-11-21T14:53:35-08:00https://www.diacarta.com/a-steadfast-dedication-for-improving-therapeutic-options-across-the-globe-diacarta2019-11-21T14:45:54-08:00https://www.diacarta.com/diacarta-dedicated-to-the-science-of-impact2019-11-21T14:40:59-08:00https://www.diacarta.com/case-study-diacarta-translational-genomics-powered-by-molecular-clamp-technology2019-11-21T14:44:38-08:00https://www.diacarta.com/cio-bulletin-announces-diacarta-inc-as-one-of-the-30-fastest-growing-companies-of-20182019-01-17T00:00:51-08:00https://www.diacarta.com/cfdna-quantitation-for-research-and-clinical-applications2019-11-21T14:35:54-08:00https://www.diacarta.com/hpv-driven-cancer-and-somatic-mutations2019-11-21T14:36:16-08:00https://www.diacarta.com/kras-codon-12-mutation-detection2019-11-21T14:28:50-08:00https://www.diacarta.com/quantivirus-sars-cov-2-test-fda-eua2020-04-13T09:47:57-07:00https://www.diacarta.com/diacarta-sars-cov-2-test-detecting-3-viral-genes-receives-us-fda-emergency-use-authorization-test-manufacturing-expanded-to-500k-covid-19-tests-week2020-04-13T09:47:03-07:00https://www.diacarta.com/covid19-mexico-cofepris2020-07-15T10:15:08-07:00https://www.diacarta.com/covid19-test-top-102020-10-06T13:32:44-07:00https://www.diacarta.com/fda-report-diacarta-covid-19-tests-rank-top-3-among-fda-sars-cov-2-reference-panel-tests2020-10-06T13:32:11-07:00https://www.diacarta.com/a-high-throughput-anti-sars-cov-2-igg-testing-platform-for-covid-192020-11-13T09:34:27-08:00https://www.diacarta.com/kinetics-of-plasma-cfdna2021-04-07T15:43:11-07:00https://www.diacarta.com/publication-in-nature-scientific-reports-cfdna-biomarker2021-04-12T11:42:31-07:00https://www.diacarta.com/xna-detects-new-sarscov2-variants2021-04-22T23:13:12-07:00https://www.diacarta.com/former-astrazeneca-personalized-healthcare-strategy-leader-named-sevior-vp2021-05-13T12:40:16-07:00https://www.diacarta.com/gauge-chemotherapy-response-in-multiple-cancers2021-05-13T14:38:21-07:00https://www.diacarta.com/ceivd-covid19-delta-plus2021-08-12T12:36:06-07:00https://www.diacarta.com/sars-cov-2-delta-variant-pcr-could-help-surveilance-effors2021-09-01T17:22:38-07:00https://www.diacarta.com/diacarta-and-the-scientific-world-mourns-the-passing-of-cso-michael-j-powell-ph-d2021-10-12T05:39:27-07:00https://www.diacarta.com/early-cancer-detection2021-11-23T14:58:45-08:00https://www.diacarta.com/assay-detects-precancerous-colorecta-cancer-lesions-mutations2021-11-29T13:49:02-08:00https://www.diacarta.com/multivariant-covid19-test-omicron2022-04-08T14:03:56-07:00https://www.diacarta.com/diagnostic-developers-pursue-sars-cov-2-omicron-assays-for-surveillance2021-12-22T15:05:07-08:00https://www.diacarta.com/crada-nci2022-04-07T17:03:59-07:00https://www.diacarta.com/jack-kaye2022-04-08T14:06:46-07:00https://www.diacarta.com/ceivd-mark-sars-cov-2-flu-ab-combo-test2022-07-21T14:50:31-07:00https://www.diacarta.com/dealing-with-the-respiratory-viruses-that-cause-covid-19-or-flu2023-03-03T16:47:22-08:00https://www.diacarta.com/diacarta-to-become-a-publicly-listed-company2022-10-20T14:36:22-07:00https://www.diacarta.com/diacarta-announces-successful-completion-of-oncuria-validation-study-with-nonagen-bioscience2023-01-05T16:37:09-08:00https://www.diacarta.com/fda-eua-mpox-pcr-test2023-01-12T16:59:07-08:00https://www.diacarta.com/aacr-20232023-04-20T23:42:46-07:00https://www.diacarta.com/accreditation-cap2023-05-10T17:35:27-07:00https://www.diacarta.com/termination-business-combination-agreement-hhl2023-07-06T15:04:25-07:00https://www.diacarta.com/hmc-hml-partnership2023-07-24T12:06:30-07:00https://www.diacarta.com/launches-otc-at-home-ifob-test2023-12-08T00:50:19-08:00https://www.diacarta.com/what-is-vexas-syndrome2024-02-06T14:08:53-08:00https://www.diacarta.com/genetic-testing-for-vexas2024-02-06T12:56:38-08:00https://www.diacarta.com/who-should-be-tested-for-vexas-syndrome2024-04-08T15:49:22-07:00https://www.diacarta.com/radtox-test-to-monitor-tumor-response-receives-medicare-coverage2024-02-20T11:25:56-08:00https://www.diacarta.com/diacartas-and-oncoassure-collaborate-to-launch-prostate-cancer-ldt2024-02-27T20:29:40-08:00https://www.diacarta.com/oncuria-bladder-cancer-test-receive-medicare2024-03-04T12:16:26-08:00https://www.diacarta.com/florida-selects-radtox2024-03-11T11:39:03-07:00https://www.diacarta.com/detection-of-fusions-gene-nsclc2024-04-08T15:54:10-07:00https://www.diacarta.com/ngs-colorectal-cancer-targeted-therapy2024-04-08T15:47:49-07:00https://www.diacarta.com/capstone-health-alliance-collaboration2024-09-03T20:20:42-07:00https://www.diacarta.com/scale-up-mpox-qpcr-test2024-09-03T20:21:29-07:00